Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors

Rachel Davis1, Karan P Singh, Razelle Kurzrock

  • 1Department of Biochemistry, Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX 75708-3154, USA.

Oncology Reports
|November 4, 2009
PubMed

Insights

Sulforaphane, a compound in cruciferous vegetables, inhibits tumor growth by blocking blood vessel formation (angiogenesis). This study reveals sulforaphane activates the FOXO transcription factor to achieve these anti-angiogenic effects.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Sulforaphane (SNF) from cruciferous vegetables shows potential for inhibiting tumor growth.
  • The precise molecular mechanisms of sulforaphane's anti-angiogenic effects remain unclear.

Purpose of the Study:

  • To investigate how sulforaphane inhibits angiogenesis via the FOXO transcription factor in human umbilical vein endothelial cells (HUVECs).

Main Methods:

  • Examined sulforaphane's effects on MEK/ERK and PI3K/AKT pathways in HUVECs.
  • Assessed the impact on cell migration, capillary tube formation, and FOXO3a nuclear translocation.
  • Utilized phosphorylation-deficient FOXO mutants to evaluate their role.

Main Results:

  • Inhibiting MEK/ERK and PI3K/AKT pathways synergistically enhanced sulforaphane's anti-angiogenic activity.
  • These pathway inhibitions promoted FOXO3a nuclear translocation and transcriptional activity.
  • Phosphorylation-deficient FOXO mutants amplified sulforaphane's anti-angiogenic effects.

Conclusions:

  • Sulforaphane activates the FOXO transcription factor, inhibiting angiogenesis and potentially controlling tumor growth.
  • These findings highlight sulforaphane's potential in cancer chemoprevention and therapy.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...